newmed energy - DKDRF

DKDRF

Close Chg Chg %
5.78 0.65 11.26%

Open Market

6.43

+0.65 (11.26%)

Volume: 300.00

Last Updated:

Apr 9, 2026, 11:34 AM EDT

Company Overview: newmed energy - DKDRF

DKDRF Key Data

Open

$6.43

Day Range

6.43 - 6.43

52 Week Range

3.82 - 7.34

Market Cap

$7.55B

Shares Outstanding

1.17B

Public Float

525.89M

Beta

0.76

Rev. Per Employee

N/A

P/E Ratio

21.99

EPS

$0.29

Yield

320.25%

Dividend

$0.06

EX-DIVIDEND DATE

Mar 24, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

1.31K

 

DKDRF Performance

1 Week
 
17.67%
 
1 Month
 
0.39%
 
3 Months
 
8.90%
 
1 Year
 
104.51%
 
5 Years
 
N/A
 

DKDRF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About newmed energy - DKDRF

Newmed Energy LP engages in exploration, development, and production of natural gas, condensate, and oil. Its operations include Leviathan, Aphrodite, New Ofek and New Yahel. The company was founded on July 25, 1993 and is headquartered in Herzliya, Israel.

DKDRF At a Glance

Newmed Energy LP
19 Abba Eban Boulevard
Herzliya, Tel Aviv 4672537
Phone 972-9-971-2424 Revenue 866.60M
Industry Integrated Oil Net Income 343.00M
Sector Energy Minerals Employees 24
Fiscal Year-end 12 / 2026
View SEC Filings

DKDRF Valuation

P/E Current 21.988
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 19.361
Price to Sales Ratio 7.675
Price to Book Ratio 3.511
Price to Cash Flow Ratio 13.16
Enterprise Value to EBITDA 10.831
Enterprise Value to Sales 8.783
Total Debt to Enterprise Value 0.147

DKDRF Efficiency

Revenue/Employee 36,108,333.333
Income Per Employee 14,291,666.667
Receivables Turnover 2.789
Total Asset Turnover 0.218

DKDRF Liquidity

Current Ratio 2.32
Quick Ratio 2.32
Cash Ratio 0.78

DKDRF Profitability

Gross Margin 62.37
Operating Margin 60.339
Pretax Margin 55.747
Net Margin 39.58
Return on Assets 8.995
Return on Equity 19.464
Return on Total Capital 11.897
Return on Invested Capital 12.058

DKDRF Capital Structure

Total Debt to Total Equity 59.094
Total Debt to Total Capital 37.144
Total Debt to Total Assets 28.172
Long-Term Debt to Equity 59.073
Long-Term Debt to Total Capital 37.131
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Newmed Energy - DKDRF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
971.90M 934.60M 973.10M 866.60M
Sales Growth
+28.94% -3.84% +4.12% -10.94%
Cost of Goods Sold (COGS) incl D&A
266.60M 231.00M 252.60M 326.10M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
137.60M 87.50M 88.70M 179.80M
Depreciation
137.60M 87.50M 88.70M 179.80M
Amortization of Intangibles
- - - -
-
COGS Growth
+12.25% -13.35% +9.35% +29.10%
Gross Income
705.30M 703.60M 720.50M 540.50M
Gross Income Growth
+36.61% -0.24% +2.40% -24.98%
Gross Profit Margin
+72.57% +75.28% +74.04% +62.37%
2022 2023 2024 2025 5-year trend
SG&A Expense
19.70M 20.80M 16.90M 17.60M
Research & Development
- - - -
-
Other SG&A
19.70M 20.80M 16.90M 17.60M
SGA Growth
+14.65% +5.58% -18.75% +4.14%
Other Operating Expense
- - - 5.20M
-
Unusual Expense
(65.60M) (2.10M) (67.60M) (30.20M)
EBIT after Unusual Expense
746.00M 684.90M 771.20M 553.10M
Non Operating Income/Expense
5.10M 15.90M 17.00M 15.50M
Non-Operating Interest Income
5.40M 13.10M 17.50M 14.40M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
153.40M 125.20M 109.90M 85.50M
Interest Expense Growth
-26.61% -18.38% -12.22% -22.20%
Gross Interest Expense
160.10M 130.40M 116.20M 106.30M
Interest Capitalized
6.70M 5.20M 6.30M 20.80M
Pretax Income
597.70M 575.60M 678.30M 483.10M
Pretax Income Growth
+86.15% -3.70% +17.84% -28.78%
Pretax Margin
+61.50% +61.59% +69.71% +55.75%
Income Tax
116.00M 142.80M 156.60M 121.50M
Income Tax - Current - Domestic
54.00M 98.70M 79.00M 116.30M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
62.00M 44.10M 77.60M 5.20M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
478.60M 431.50M 524.60M 358.00M
Minority Interest Expense
- - - -
-
Net Income
478.60M 431.50M 524.60M 358.00M
Net Income Growth
+340.08% -9.84% +21.58% -31.76%
Net Margin Growth
+49.24% +46.17% +53.91% +41.31%
Extraordinaries & Discontinued Operations
- (13.20M) 2.10M (15.00M)
Discontinued Operations
- (13.20M) 2.10M (15.00M)
Net Income After Extraordinaries
465.40M 433.60M 524.60M 343.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
465.40M 433.60M 524.60M 343.00M
EPS (Basic)
0.3965 0.3694 0.4469 0.2922
EPS (Basic) Growth
+78.68% -6.83% +20.98% -34.62%
Basic Shares Outstanding
1.17B 1.17B 1.17B 1.17B
EPS (Diluted)
0.3965 0.3694 0.4469 0.2918
EPS (Diluted) Growth
+78.68% -6.83% +20.98% -34.71%
Diluted Shares Outstanding
1.17B 1.17B 1.17B 1.18B
EBITDA
818.00M 770.30M 792.30M 702.70M
EBITDA Growth
+29.39% -5.83% +2.86% -11.31%
EBITDA Margin
+84.17% +82.42% +81.42% +81.09%

Newmed Energy in the News